Latest lung disease News | Page 3

Malfunctioning immune cell behaviour could be drug target in Long Covid
Call for Manchester volunteers in dementia/Alzheimer’s pollution link study
Victoria Backs National Ban On Deadly Engineered Stone
Statement on WHS Ministers’ Meeting
Children’s lung capacity improved in cleaner air
Monash Expert: Concerns grow about silicosis
COVID-19 vaccine available for younger children at higher risk of severe illness
Longstanding WHO partners to enter into official relations with the Organization
Australians deserve more out of Medicare
Discovery could open door to new COPD treatment
Melioidosis cases on rise 30 December
How to protect yourself against bushfire smoke this summer
Less infectious particles from children’s lungs
NIH funds antibiotic trial for HIV and emphysema
Datopotamab deruxtecan showed promising responses as monotherapy and in combination with Imfinzi
Datopotamab deruxtecan showed encouraging and durable efficacy in patients with heavily pretreated HR-positive
Experimental vaccines offer long-term protection against severe COVID
More must be done to manage asbestos risks
Nearly two thirds of Australians are complacent about Covid despite emergence of new wave
Using Vapes May Set Stage for Dental Decay
ATAGI recommendations on use of Pfizer Covid vaccine for children aged 6 months to 4 years
New computational method builds detailed maps of human tissues
Update on MESSINA Phase III trial for Fasenra in eosinophilic esophagitis
Cleaner emissions standards for trucks and buses
Changes to workplace exposure standard for respirable coal dust
New workplace coal dust standard commences in Queensland
ATAGI recommend Covid vaccination for some children aged 6 months to under 5 years
Children and high-risk populations immune responses to vaccinations and Covid going under microscope
World first online singing trial for people with chronic lung disease
Prestigious grant to profile responses to Covid vaccines in vulnerable people
Immunocompromised children under 5 now eligible for Covid vaccine
Treatment for fatal lung disease in babies closer
Enhertu significantly delayed disease progression in DESTINY-Breast02 Phase III trial vs. physician’s choice of treatment
Remembering Olivia Newton-John and Judith Durham – Aussie Queens of song
Datopotamab deruxtecan-based combinations show promising clinical activity
Enhertu approved in US as first HER2-directed therapy for patients with HER2-low metastatic breast cancer
Recruitment open for new study of lung disease
Enhertu granted Priority Review in US for patients with HER2-low metastatic breast cancer
AMA calls out Premier Palaszczuk for lack of consultation on pharmacy trial
QLD Premier must consult on pharmacy prescribing trial
Australia’s first national biotechnology incubator announces round one funding
Enhertu approved in EU for patients with HER2-positive metastatic breast cancer treated with one or more prior anti-HER2-based
Cynata Therapeutics secures US patent for Use of Cymerus MSCs in Asthma
Curtin University study backs AWU’s alarm at extent of workplace silicosis health risk
Mobile Health Unit at Opal Festival
Inhalable Covid Vaccine Shows Promise in Rodent Model
Top 3 questions – Oral Treatments for Covid with Dr Lucas de Toca
New drug target identified for inflammatory lung disease